Whittier Trust Co. of Nevada Inc. Has $680,000 Stake in CVS Health Co. (NYSE:CVS)

Whittier Trust Co. of Nevada Inc. lowered its holdings in CVS Health Co. (NYSE:CVS) by 3.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 15,142 shares of the pharmacy operator’s stock after selling 563 shares during the quarter. Whittier Trust Co. of Nevada Inc.’s holdings in CVS Health were worth $680,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Legacy Investment Solutions LLC acquired a new stake in CVS Health in the 3rd quarter valued at $31,000. Ridgewood Investments LLC boosted its holdings in CVS Health by 255.7% during the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 450 shares during the last quarter. Stonebridge Financial Group LLC purchased a new position in CVS Health during the 4th quarter worth $28,000. RPg Family Wealth Advisory LLC purchased a new position in CVS Health during the 3rd quarter worth $40,000. Finally, Hopwood Financial Services Inc. purchased a new position in CVS Health during the 4th quarter worth $29,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Stock Down 2.1 %

CVS stock opened at $67.22 on Friday. CVS Health Co. has a twelve month low of $43.56 and a twelve month high of $80.75. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80. The firm has a market capitalization of $84.75 billion, a PE ratio of 18.37, a PEG ratio of 0.98 and a beta of 0.54. The stock has a 50-day simple moving average of $60.60 and a two-hundred day simple moving average of $57.35.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. On average, equities analysts predict that CVS Health Co. will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd will be issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.96%. The ex-dividend date is Tuesday, April 22nd. CVS Health’s payout ratio is 72.68%.

Wall Street Analysts Forecast Growth

CVS has been the topic of a number of recent analyst reports. Leerink Partners upgraded CVS Health from a “market perform” rating to an “outperform” rating and lifted their target price for the stock from $55.00 to $75.00 in a research note on Thursday, February 13th. Argus set a $77.00 target price on CVS Health in a research note on Tuesday, February 18th. TD Cowen lifted their target price on CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research note on Monday, November 25th. Wolfe Research lifted their target price on CVS Health from 67.00 to 70.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 11th. Finally, Leerink Partnrs upgraded CVS Health from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, February 12th. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, CVS Health presently has a consensus rating of “Moderate Buy” and an average target price of $70.39.

Insiders Place Their Bets

In related news, Director Michael F. Mahoney acquired 30,000 shares of the stock in a transaction on Tuesday, February 18th. The stock was purchased at an average price of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the transaction, the director now owns 39,356 shares of the company’s stock, valued at $2,625,045.20. This trade represents a 320.65 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP James David Clark sold 7,513 shares of the business’s stock in a transaction that occurred on Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total value of $498,487.55. Following the completion of the sale, the senior vice president now owns 8,394 shares of the company’s stock, valued at $556,941.90. The trade was a 47.23 % decrease in their position. The disclosure for this sale can be found here. 0.24% of the stock is owned by insiders.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.